To understand the key metabolic driver pathways critical for pancreatic cancer progression, we used the AlamarBlue assay to determine synthetic CB1 cannabinoids to induce the cell’s metabolic viability drivers to stage migratory intercellular communication. Here, CNR1 is linked to pancreatic neoplasm.